We are live on ! Find out more
2L

22NW LP Portfolio holdings

AUM $146M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
AUM
$146M
AUM Growth
-$91.7M
Cap. Flow
-$83.1M
Cap. Flow %
-56.95%
Top 10 Hldgs %
90.14%
Holding
21
New
1
Increased
3
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
NSP icon
Insperity
NSP
+$12.8M
2
FOXF icon
Fox Factory Holding Corp
FOXF
+$12.3M
3
MLYS icon
Mineralys Therapeutics
MLYS
+$2.52M
4
SRI icon
Stoneridge
SRI
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 40.93%
2 Industrials 31.4%
3 Consumer Discretionary 21.39%
4 Materials 3.42%
5 Consumer Staples 1.7%

No holdings matched the selected filter criteria.

Similar funds

22NW LP's Q1 2026 Portfolio in Review

As of Q1 2026, 22NW LP held 21 positions worth $146M, down 39% from $238M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

22NW LP withdrew a net $83.1M in Q1 2026, closing 5 positions and reducing 4 holdings. Its most notable exit was Anebulo Pharmaceuticals, an estimated $84.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 66% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, 22NW LP opened a new position in Fox Factory Holding Corp worth $11.2M.

  • 22NW LP's largest Q1 2026 buy was Fox Factory Holding Corp: 678,165 shares worth $11.2M.
  • 22NW LP added most to Insperity in Q1 2026, an estimated $12.8M increase.
  • 22NW LP's biggest Q1 2026 reduction was Regenxbio, cutting an estimated $4.53M.
  • 22NW LP fully exited Anebulo Pharmaceuticals in Q1 2026, selling an estimated $84.8M.
  • 22NW LP's ten largest holdings make up 90% of its $146M portfolio in Q1 2026.
  • 22NW LP opened 1 new position and closed 5 in Q1 2026.
  • 22NW LP's portfolio value fell 39% quarter-over-quarter to $146M.

Based on 22NW LP's 13F filing for Q1 2026, filed 15 May 2026.